drugset / Trial / NCT00516737

Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)

NCT00516737

Phase 3 Completed 207 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the effectiveness of rizatriptan benzoate in the early treatment of an acute migraine attack.

Timeline

Start
2007-10-03
Primary completion
2008-04-08
Completion
2008-04-08

Drugs

EvaluationDrugModalityDoseRoute
Subject rizatriptan Unknown 10 mg Oral

Indications